Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1298

1.

CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function.

Mittal D, Lepletier A, Madore J, Aguilera AR, Stannard K, Blake SJ, Whitehall VLJ, Liu C, Bettington ML, Takeda K, Long GV, Scolyer RA, Lan R, Siemers N, Korman A, Teng MWL, Johnston RJ, Dougall WC, Smyth MJ.

Cancer Immunol Res. 2019 Mar 20. doi: 10.1158/2326-6066.CIR-18-0637. [Epub ahead of print]

PMID:
30894377
2.

Syntenin regulates Hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomes.

Deng L, Jiang W, Wang X, Merz A, Hiet MS, Chen Y, Pan X, Jiu Y, Yang Y, Yu B, He Y, Tu Z, Niu J, Bartenschlager R, Long G.

J Hepatol. 2019 Mar 14. pii: S0168-8278(19)30147-3. doi: 10.1016/j.jhep.2019.03.006. [Epub ahead of print]

PMID:
30880226
3.

Multiple EIT and EIA in optical microresonators.

Wang T, Hu YQ, Du CG, Long GL.

Opt Express. 2019 Mar 4;27(5):7344-7353. doi: 10.1364/OE.27.007344.

PMID:
30876299
4.

Theoretical Prediction of Chiral 3D Hybrid Organic-Inorganic Perovskites.

Long G, Zhou Y, Zhang M, Sabatini R, Rasmita A, Huang L, Lakhwani G, Gao W.

Adv Mater. 2019 Mar 15:e1807628. doi: 10.1002/adma.201807628. [Epub ahead of print]

PMID:
30873689
5.

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients.

Lee JH, Saw RP, Thompson JF, Lo S, Spillane AJ, Shannon KF, Stretch J, Howle J, Menzies AM, Carlino MS, Kefford RF, Long GV, Scolyer RA, Rizos H.

Ann Oncol. 2019 Mar 12. pii: mdz075. doi: 10.1093/annonc/mdz075. [Epub ahead of print]

PMID:
30860590
6.

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas.

Quek C, Rawson RV, Ferguson PM, Shang P, Silva I, Saw RPM, Shannon K, Thompson JF, Hayward NK, Long GV, Mann GJ, Scolyer RA, Wilmott JS.

Oncotarget. 2019 Jan 29;10(9):930-941. doi: 10.18632/oncotarget.26584. eCollection 2019 Jan 29.

7.

Making a difference to many.

Long GV.

Nat Med. 2019 Mar;25(3):356. doi: 10.1038/s41591-019-0390-x. No abstract available.

PMID:
30842664
8.

Somatic hypermutation of the YAP oncogene in a human cutaneous melanoma.

Zhang X, Tang JZ, Vergara IA, Zhang Y, Szeto P, Yang L, Mintoff C, Colebatch A, Mcintosh L, Mitchell KA, Shaw E, Rizos H, Long GV, Hayward N, McArthur GA, Papenfuss AT, Harvey KF, Shackleton M.

Mol Cancer Res. 2019 Mar 4. pii: molcanres.0407.2018. doi: 10.1158/1541-7786.MCR-18-0407. [Epub ahead of print]

PMID:
30833299
9.

Reply to A. Shinde et al.

Kluger HM, Margolin KA, Davies MA, Long GV, Tawbi HA, Goldberg SB, Chiang VL.

J Clin Oncol. 2019 Feb 26:JCO1802463. doi: 10.1200/JCO.18.02463. [Epub ahead of print] No abstract available.

PMID:
30807233
10.

Prevalence and cellular distribution of novel immune checkpoint targets across longitudinal specimens in treatment-naïve melanoma: implications for clinical trials.

Edwards JJ, Tasker A, Silva I, Quek C, Batten M, Ferguson AL, Allen R, Allanson BM, Saw RP, Thompson JF, Menzies AM, Palendira U, Wilmott JS, Long G, Scolyer RA.

Clin Cancer Res. 2019 Feb 18. pii: clincanres.4011.2018. doi: 10.1158/1078-0432.CCR-18-4011. [Epub ahead of print]

PMID:
30777877
11.

Molecular genomic profiling of melanocytic nevi.

Colebatch AJ, Ferguson P, Newell F, Kazakoff SH, Witkowski T, Dobrovic A, Johansson PA, Saw RP, Stretch JR, McArthur GA, Long GV, Thompson JF, Pearson JV, Mann GJ, Hayward NK, Waddell N, Scolyer RA, Wilmott JS.

J Invest Dermatol. 2019 Feb 14. pii: S0022-202X(19)30118-6. doi: 10.1016/j.jid.2018.12.033. [Epub ahead of print]

PMID:
30772300
12.

Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies.

Pires da Silva I, Glitza IC, Haydu LE, Johnpulle R, Banks PD, Grass GD, Goldinger SMA, Smith JL, Everett AS, Koelblinger P, Roberts-Thomson R, Millward M, Atkinson VG, Guminski A, Kapoor R, Conry RM, Carlino MS, Wang W, Shackleton MJ, Eroglu Z, Lo S, Hong AM, Long GV, Johnson DB, Menzies AM.

Pigment Cell Melanoma Res. 2019 Feb 15. doi: 10.1111/pcmr.12775. [Epub ahead of print]

PMID:
30767428
13.

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.

Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, Madore J, Lim SY, Velickovic R, Wongchenko M, Yan Y, Lo S, Carlino MS, Guminski A, Saw RPM, Pang A, McGuire HM, Palendira U, Thompson JF, Rizos H, Silva IPD, Batten M, Scolyer RA, Long GV, Wilmott JS.

Cancer Cell. 2019 Feb 11;35(2):238-255.e6. doi: 10.1016/j.ccell.2019.01.003.

PMID:
30753825
14.

Implementation and security analysis of practical quantum secure direct communication.

Qi R, Sun Z, Lin Z, Niu P, Hao W, Song L, Huang Q, Gao J, Yin L, Long GL.

Light Sci Appl. 2019 Feb 6;8:22. doi: 10.1038/s41377-019-0132-3. eCollection 2019.

15.

Assessment of Potential Mercury Toxicity to Native Invertebrates in a High-Gradient Stream.

Flanders JR, Long G, Reese B, Grosso N, Clements W, Stahl R Jr.

Integr Environ Assess Manag. 2019 Feb 6. doi: 10.1002/ieam.4133. [Epub ahead of print]

PMID:
30724482
16.

Intrinsic valley Hall transport in atomically thin MoS2.

Wu Z, Zhou BT, Cai X, Cheung P, Liu GB, Huang M, Lin J, Han T, An L, Wang Y, Xu S, Long G, Cheng C, Law KT, Zhang F, Wang N.

Nat Commun. 2019 Feb 5;10(1):611. doi: 10.1038/s41467-019-08629-9.

17.

Determining Interaction Enhanced Valley Susceptibility in Spin-Valley-Locked MoS2.

Lin J, Han T, Piot BA, Wu Z, Xu S, Long G, An L, Cheung P, Zheng PP, Plochocka P, Dai X, Maude DK, Zhang F, Wang N.

Nano Lett. 2019 Mar 13;19(3):1736-1742. doi: 10.1021/acs.nanolett.8b04731. Epub 2019 Feb 7.

PMID:
30720286
18.

Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients.

Lee H, Quek C, Silva I, Tasker A, Batten M, Rizos H, Lim SY, Nur Gide T, Shang P, Attrill GH, Madore J, Edwards J, Carlino MS, Guminski A, Saw RPM, Thompson JF, Ferguson PM, Palendira U, Menzies AM, Long GV, Scolyer RA, Wilmott JS.

Oncoimmunology. 2018 Oct 31;8(2):e1537581. doi: 10.1080/2162402X.2018.1537581. eCollection 2019.

PMID:
30713793
20.

Protective and Detoxifying Enzyme Activity and ABCG Subfamily Gene Expression in Sogatella furcifera Under Insecticide Stress.

Zhou C, Yang H, Wang Z, Long GY, Jin DC.

Front Physiol. 2019 Jan 8;9:1890. doi: 10.3389/fphys.2018.01890. eCollection 2018.

21.

Data for ampholytic ion-exchange materials coated with small zwitterions for high-efficacy purification of ionizable soluble biomacromolecules.

Rao J, Liao J, Bu Y, Wang Y, Hu X, Long G, Huang M, Zhong L, Yang X, Liao F.

Data Brief. 2018 Oct 3;21:709-720. doi: 10.1016/j.dib.2018.09.102. eCollection 2018 Dec.

22.

Pharmacokinetic and cytokine profiles of melanoma patients with dabrafenib and trametinib-induced pyrexia.

Kim HY, Duong JK, Gonzalez M, Long GV, Menzies AM, Rizos H, Lim SY, Lee J, Boddy AV.

Cancer Chemother Pharmacol. 2019 Apr;83(4):693-704. doi: 10.1007/s00280-019-03780-y. Epub 2019 Jan 19.

PMID:
30661097
23.

Characterization of microresonator-geometry-deformation for cavity optomechanics.

Wang M, Wang YZ, Xu XS, Hu YQ, Long GL.

Opt Express. 2019 Jan 7;27(1):63-73. doi: 10.1364/OE.27.000063.

PMID:
30645359
24.

Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma.

Pires da Silva I, Wang KYX, Wilmott JS, Holst J, Carlino MS, Park JJ, Quek C, Wongchenko M, Yan Y, Mann G, Johnson DB, McQuade JL, Rai R, Kefford RF, Rizos H, Scolyer RA, Yang JYH, Long GV, Menzies AM.

Clin Cancer Res. 2019 Feb 15;25(4):1272-1279. doi: 10.1158/1078-0432.CCR-18-1680. Epub 2019 Jan 10.

PMID:
30630828
25.

Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.

Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, Sun Y, Chen XZ, Li JG, Zhu XD, Hu CS, Xu XY, Chen YY, Hu WH, Guo L, Mo HY, Chen L, Mao YP, Sun R, Ai P, Liang SB, Long GX, Zheng BM, Feng XL, Gong XC, Li L, Shen CY, Xu JY, Guo Y, Chen YM, Zhang F, Lin L, Tang LL, Liu MZ, Ma J, Sun Y.

Int J Cancer. 2019 Jan 6. doi: 10.1002/ijc.32099. [Epub ahead of print]

PMID:
30613964
26.

Inter- and intra-patient heterogeneity of indoleamine 2,3-dioxygenase expression in primary and metastatic melanoma cells and the tumor microenvironment.

Gide TN, Allanson BM, Menzies AM, Ferguson PM, Madore J, Saw RPM, Thompson JF, Long GV, Wilmott JS, Scolyer RA.

Histopathology. 2018 Dec 27. doi: 10.1111/his.13814. [Epub ahead of print]

PMID:
30589949
27.

[Knockdown of SOX9 enhances apoptosis of laryngeal squamous cell carcinoma cells induced by As2O3].

Zhang H, Long G, Wei W, Li Z.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018 Oct;34(10):885-890. Chinese.

PMID:
30554581
28.

Synthesis, Photophysical Properties and Two-Photon Absorption Study of Tetraazachrysene-based N-Heteroacenes.

Li G, Wang S, Yang S, Liu G, Hao P, Zheng Y, Long G, Li D, Zhang Y, Yang W, Xu L, Gao W, Zhang Q, Cui G, Tang B.

Chem Asian J. 2018 Dec 13. doi: 10.1002/asia.201801656. [Epub ahead of print]

PMID:
30548955
29.

Illumina-based transcriptomic analysis on recalcitrant seeds of Panax notoginseng for the dormancy release during the after-ripening process.

Yang K, Yang L, Fan W, Long GQ, Xie SQ, Meng ZG, Zhang GH, Yang SC, Chen JW.

Physiol Plant. 2018 Dec 12. doi: 10.1111/ppl.12904. [Epub ahead of print]

PMID:
30548605
30.

Analysis of Nanomaterial Toxicity by Western Blot.

Long G, Mo Y, Zhang Q, Jiang M.

Methods Mol Biol. 2019;1894:161-169. doi: 10.1007/978-1-4939-8916-4_10.

PMID:
30547461
31.

Supramolecular Design of Donor-Acceptor Complexes via Heteroatom Replacement towards Structure and Electrical Transporting Property Tailoring.

Jin J, Long G, Gao Y, Zhang J, Ou C, Zhu C, Xu H, Zhao J, Zhang M, Huang W.

ACS Appl Mater Interfaces. 2018 Dec 12. doi: 10.1021/acsami.8b16561. [Epub ahead of print]

PMID:
30540179
32.

Precision medicine in COPD: review of mepolizumab for eosinophilic COPD.

Long G, Wall J.

Breathe (Sheff). 2018 Dec;14(4):338-341. doi: 10.1183/20734735.026318.

33.

Clinical Effectiveness of the Posterior Affected-Vertebrae Fixation Method in Posterior-Anterior Surgery to Treat Thoracic Spinal Tuberculosis.

Liang Q, Wang Q, Long G, Ma W, Jin W, Liu L, Wu Y, Shi J, Wang Z.

World Neurosurg. 2019 Mar;123:29-39. doi: 10.1016/j.wneu.2018.11.199. Epub 2018 Nov 29.

PMID:
30503294
34.

Unigene-based RNA-seq provides insights on drought stress responses in Marsdenia tenacissima.

Meng HL, Zhang W, Zhang GH, Wang JJ, Meng ZG, Long GQ, Yang SC.

PLoS One. 2018 Nov 30;13(11):e0202848. doi: 10.1371/journal.pone.0202848. eCollection 2018.

35.

Primary anorectal melanoma: clinical, immunohistology and DNA analysis of 43 cases.

Dodds TJ, Wilmott JS, Jackett LA, Lo SN, Long GV, Thompson JF, Scolyer RA.

Pathology. 2019 Jan;51(1):39-45. doi: 10.1016/j.pathol.2018.09.060. Epub 2018 Nov 26.

PMID:
30497801
36.

Analysis of risk factors and development of scoring system to predict severity of upper gastrointestinal bleeding in children.

Zheng W, Jiang L, Jia X, Long G, Shu X, Jiang M.

J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14548. [Epub ahead of print]

PMID:
30462839
37.

Binding of cellular nucleolin with the viral core RNA G-quadruplex structure suppresses HCV replication.

Bian WX, Xie Y, Wang XN, Xu GH, Fu BS, Li S, Long G, Zhou X, Zhang XL.

Nucleic Acids Res. 2019 Jan 10;47(1):56-68. doi: 10.1093/nar/gky1177.

38.

Early Indices of Reduced Cochlear Function in Young Adults with Type-1 Diabetes Revealed by DPOAE Fine Structure.

Spankovich C, Long GR, Hood LJ.

J Am Acad Audiol. 2018 Sep 25. doi: 10.3766/jaaa.17113. [Epub ahead of print]

PMID:
30461415
39.

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.

Ascierto PA, Long GV, Robert C, Brady B, Dutriaux C, Di Giacomo AM, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebbé C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Ny L, Arance A, Svane IM, Schadendorf D, Gogas H, Saci A, Jiang J, Rizzo J, Atkinson V.

JAMA Oncol. 2018 Oct 25. doi: 10.1001/jamaoncol.2018.4514. [Epub ahead of print]

PMID:
30422243
40.

Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy.

Lim SY, Lee JH, Gide TN, Menzies AM, Guminski A, Carlino MS, Breen EJ, Yang JYH, Ghazanfar S, Kefford RF, Scolyer RA, Long GV, Rizos H.

Clin Cancer Res. 2019 Mar 1;25(5):1557-1563. doi: 10.1158/1078-0432.CCR-18-2795. Epub 2018 Nov 8.

PMID:
30409824
41.

Epigenetic profiling for the molecular classification of metastatic brain tumors.

Orozco JIJ, Knijnenburg TA, Manughian-Peter AO, Salomon MP, Barkhoudarian G, Jalas JR, Wilmott JS, Hothi P, Wang X, Takasumi Y, Buckland ME, Thompson JF, Long GV, Cobbs CS, Shmulevich I, Kelly DF, Scolyer RA, Hoon DSB, Marzese DM.

Nat Commun. 2018 Nov 6;9(1):4627. doi: 10.1038/s41467-018-06715-y.

42.

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection.

Tio M, Rai R, Ezeoke OM, McQuade JL, Zimmer L, Khoo C, Park JJ, Spain L, Turajlic S, Ardolino L, Yip D, Goldinger SM, Cohen JV, Millward M, Atkinson V, Kane AY, Ascierto PA, Garbe C, Gutzmer R, Johnson DB, Rizvi HA, Joshua AM, Hellmann MD, Long GV, Menzies AM.

Eur J Cancer. 2018 Nov;104:137-144. doi: 10.1016/j.ejca.2018.09.017. Epub 2018 Oct 20.

PMID:
30347289
43.

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma.

Hauschild A, Dummer R, Schadendorf D, Santinami M, Atkinson V, Mandalà M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Lesimple T, Plummer R, Dasgupta K, Haas T, Shilkrut M, Gasal E, Kefford R, Kirkwood JM, Long GV.

J Clin Oncol. 2018 Oct 22:JCO1801219. doi: 10.1200/JCO.18.01219. [Epub ahead of print]

44.

SIRT1 knock-in mice preserve ovarian reserve resembling caloric restriction.

Long GY, Yang JY, Xu JJ, Ni YH, Zhou XL, Ma JY, Fu YC, Luo LL.

Gene. 2019 Feb 20;686:194-202. doi: 10.1016/j.gene.2018.10.040. Epub 2018 Oct 17.

PMID:
30340050
45.

Relationship Between SLC22A1 and SLC22A4 Gene Polymorphisms and Risk of Type 2 Diabetes in Chinese Han Population.

Long G, Zhang G, Zhang F, Ye D, Yang D, Yang Y.

Clin Lab. 2018 Sep 1;64(9):1357-1361. doi: 10.7754/Clin.Lab.2018.180129.

PMID:
30274012
46.

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.

Wang DY, Salem JE, Cohen JV, Chandra S, Menzer C, Ye F, Zhao S, Das S, Beckermann KE, Ha L, Rathmell WK, Ancell KK, Balko JM, Bowman C, Davis EJ, Chism DD, Horn L, Long GV, Carlino MS, Lebrun-Vignes B, Eroglu Z, Hassel JC, Menzies AM, Sosman JA, Sullivan RJ, Moslehi JJ, Johnson DB.

JAMA Oncol. 2018 Dec 1;4(12):1721-1728. doi: 10.1001/jamaoncol.2018.3923.

PMID:
30242316
47.

Patterns of Response and Progression to Immunotherapy.

Borcoman E, Nandikolla A, Long G, Goel S, Le Tourneau C.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):169-178. doi: 10.1200/EDBK_200643. Review.

PMID:
30231380
48.

Two-copy Quantum Teleportation.

Quan Q, Zhao MJ, Fei SM, Fan H, Yang WL, Long GL.

Sci Rep. 2018 Sep 18;8(1):13960. doi: 10.1038/s41598-018-31918-0.

49.

Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer.

Long GV, Tykodi SS, Schneider JG, Garbe C, Gravis G, Rashford M, Agrawal S, Grigoryeva E, Bello A, Roy A, Rollin L, Zhao X.

Ann Oncol. 2018 Nov 1;29(11):2208-2213. doi: 10.1093/annonc/mdy408.

50.

bcGST - an interactive bias-correction method to identify over-represented gene-sets in boutique arrays.

Wang KYX, Menzies AM, Silva IP, Wilmott JS, Yan Y, Wongchenko M, Kefford RF, Scolyer RA, Long GV, Tarr G, Mueller S, Yang JYH.

Bioinformatics. 2018 Sep 12. doi: 10.1093/bioinformatics/bty783. [Epub ahead of print]

PMID:
30215668

Supplemental Content

Support Center